Absence of JAK2 V617F mutation in gastric cancers

被引：19

作者：

Lee, JW ^{[1
]}

Soung, YH ^{[1
]}

Kim, SY ^{[1
]}

Nam, SW ^{[1
]}

Park, WS ^{[1
]}

Lee, JY ^{[1
]}

Yoo, NJ ^{[1
]}

Lee, SH ^{[1
]}

机构：

[1] Catholic Univ Korea, Coll Med, Dept Pathol, Seoul 137701, South Korea

来源：

ACTA ONCOLOGICA | 2006年 / 45卷 / 02期

关键词：

D O I：

10.1080/02841860500341223

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：222 / 223

页数：2

共 5 条

[1] A road map for those who don't know JAK-STAT [J].

Aaronson, DS ;

Horvath, CM .

SCIENCE, 2002, 296 (5573) :1653-1655

[2] Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy [J].

Gschwind, A ;

Fischer, OM ;

Ullrich, A .

NATURE REVIEWS CANCER, 2004, 4 (05) :361-370

[3] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].

James, C ;

Ugo, V ;

Le Couédic, JP ;

Staerk, J ;

Delhommeau, F ;

Lacout, C ;

Garçon, L ;

Raslova, H ;

Berger, R ;

Bennaceur-Griscelli, A ;

Villeval, JL ;

Constantinescu, SN ;

Casadevall, N ;

Vainchenker, W .

NATURE, 2005, 434 (7037) :1144-1148

[4] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis [J].

Levine, RL ;

Wadleigh, M ;

Cools, J ;

Ebert, BL ;

Wernig, G ;

Huntly, BJP ;

Boggon, TJ ;

Wlodarska, L ;

Clark, JJ ;

Moore, S ;

Adelsperger, J ;

Koo, S ;

Lee, JC ;

Gabriel, S ;

Mercher, T ;

D'Andrea, A ;

Fröhling, S ;

Döhner, K ;

Marynen, P ;

Vandenberghe, P ;

Mesa, RA ;

Tefferi, A ;

Griffin, JD ;

Eck, MJ ;

Sellers, WR ;

Meyerson, M ;

Golub, TR ;

Lee, SJ ;

Gilliland, DG .

CANCER CELL, 2005, 7 (04) :387-397

[5] Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line [J].

To, KF ;

Chan, MWY ;

Leung, WK ;

Ng, EKW ;

Yu, J ;

Bai, AHC ;

Lo, AWI ;

Chu, SH ;

Tong, JHM ;

Lo, KW ;

Sung, JJY ;

Chan, FKL .

BRITISH JOURNAL OF CANCER, 2004, 91 (07) :1335-1341

← 1 →